This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Important Information Regarding the Voluntary Recall of the Children's Product Hyland's Teething Tablets
- Starting date:
- October 27, 2010
- Posting date:
- October 27, 2010
- Type of communication:
- Information Update
- Subcategory:
- Affects children, pregnant or breast feeding women
- Source of recall:
- Health Canada
- Issue:
- Product Safety, Non-medicinal Ingredient, Dosage
- Audience:
- General Public
- Identification number:
- RA-110003871
Reason
What you should do
Depth of distribution
Background
Affected products
Report health or safety concerns
Media enquiries
Public enquiries
What Health Canada is doing
Hyland's Homeopathic Canada (Hyland's), a division of Standard Homeopathic Company, in consultation with Health Canada, is voluntarily recalling its Hyland's Teething Tablets from the Canadian market because they may pose a risk to children, according to U.S. Food and Drug Administration (FDA) testing.
Reason
Hyland's Teething Tablets are manufactured to contain a small amount of belladonna, a substance that can cause serious harm at larger doses. For such a product, it is important that the amount of belladonna be carefully controlled.
What you should do
Canadians who have concerns about these products should consult with their health care practitioners.
For more information on Hyland's Homeopathic Canada recall, Canadians can call 1-800-363-8933.
Depth of distribution
This recall has been initiated in both Canada and the U.S. as a precautionary measure due to the FDA's ongoing inspection of Standard Homeopathic Company's manufacturing facility in the U.S. Hyland's Teething Tablets are manufactured in the U.S. and distributed throughout North America, including Canada.
Background
The FDA has received reports of serious adverse events in children taking this product that are consistent with belladonna toxicity but conclusive links have not been formally determined. Please visit the FDA website for more information.
As of today, Health Canada has not received any adverse reactions regarding Hyland's Teething Tablets.
Affected products
Hyland's Teething Tablets, 125 tablets, DIN 01956485 (as per product label)
Product description
Hyland's Teething Tablets are sold in pharmacies, retail stores, and on the Internet as an over-the-counter (OTC) homeopathic drug intended to provide temporary relief of symptoms related to teething in children.
Report health or safety concerns
You can report any adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following three ways:
- Report online at the MedEffect™ Canada section of the Health Canada website
- Call toll-free at 1-866-234-2345
-
Complete a Canada Vigilance Reporting Form and either:
- Fax toll-free to 1-866-678-6789
-
Mail to:
Canada Vigilance Program
Health Canada
AL 0701D
Ottawa, ON K1A 0K9
To have postage pre-paid, download the postage paid label from the MedEffect™ Canada section of the Health Canada website. The Canada Vigilance Reporting Form and the adverse reaction reporting guidelines may also be obtained via this section.
Media enquiries
Health Canada
613-957-2983
Public enquiries
613-957-2991
1-866-225-0709
What Health Canada is doing
Canadians can be confident that Health Canada will be working with Hyland's Homeopathic Canada and the FDA to review their corrective actions taken at the U.S. plant where these products were manufactured.
Should new information become available, Health Canada will advise Canadians and Canadian health care professionals as soon as it is available.
Health Canada will continue monitoring the safety of health products on the Canadian market manufactured at Standard Homeopathic Company's facility and will inform Canadians if new safety information arises. Canadians can be confident that should any risks to health be identified, Health Canada will take immediate and appropriate action to help protect the health and safety of Canadians.